Building a better treatment model for Sjögren's syndrome
Part of Immune system & allergy clinical trials.
This study is building a new model to help doctors treat primary Sjögren's syndrome using a combination of traditional Chinese medicine and Western medicine. It may help find better ways to manage your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have primary Sjögren's syndrome, diagnosed using the 2002 or 2016 standard criteria.
- You cannot have any other connective tissue diseases (like lupus or rheumatoid arthritis).
- You cannot be pregnant or breastfeeding.
- You cannot have severe heart or blood vessel disease, liver or kidney failure, or a serious cancer.
- You must not have any other condition that the study doctors think would make it unsafe to participate (like severe memory problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding traditional Chinese medicine to standard care can help repair gland damage caused by Sjögren's syndrome. It is for people with primary Sjögren's who have a specific traditional Chinese medicine pattern called 'qi and yin deficiency'.
This study tests a new medicine called ESG206, which is designed to calm the immune system and reduce the symptoms of Sjögren's syndrome. If you join, you may get this medicine or a placebo, and the study will see if it safely helps with things like dry eyes and dry mouth.
This study tests an investigational drug called RSLV-132 in women with Sjögren's disease to see if it can reduce symptoms like fatigue and dryness. You may join if you've been diagnosed in the last 30 years and have persistent symptoms.
This study tests an investigational drug called CM336 for people with active Sjögren's syndrome. It aims to see if the drug is safe and effective in reducing symptoms like joint pain and dryness when other treatments haven't worked well.
This study tests a new medicine called ICP-488 for people with primary Sjögren's syndrome. It may help reduce symptoms like dry eyes and dry mouth by calming the immune system. The trial lasts about 48 weeks and includes regular check-ups.
This clinical trial tests a new drug called telitacicept for people who have both Sjögren's syndrome and interstitial lung disease. The drug aims to reduce the immune system's attack on your body and may help improve lung symptoms.
Hear when a new Primary Sjögren Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.